FOXA1
Reaktivität: Human
WB, IHC
Wirt: Kaninchen
Polyclonal
unconjugated
Applikationshinweise
Optimal working dilution should be determined by the investigator.
Beschränkungen
Nur für Forschungszwecke einsetzbar
Buffer
In 1x PBS, pH 7.4
Handhabung
Aliquot to avoid repeated freezing and thawing.
Lagerung
-20 °C
Informationen zur Lagerung
Store at -20°C or lower. Aliquot to avoid repeated freezing and thawing.
Kobayashi, Iwaya, Moriya, Yamasaki, Tsuda, Yamamoto, Matsubara: "A simple immunohistochemical panel comprising 2 conventional markers, Ki67 and p53, is a powerful tool for predicting patient outcome in luminal-type breast cancer." in: BMC clinical pathology, Vol. 13, pp. 5, (2013) (PubMed).
Braun, Mietzsch, Seibold, Schneeweiss, Schirmacher, Chang-Claude, Peter Sinn, Aulmann: "Intrinsic breast cancer subtypes defined by estrogen receptor signalling-prognostic relevance of progesterone receptor loss." in: Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc, Vol. 26, Issue 9, pp. 1161-71, (2013) (PubMed).
Jacquemier, Charafe-Jauffret, Monville, Esterni, Extra, Houvenaeghel, Xerri, Bertucci, Birnbaum: "Association of GATA3, P53, Ki67 status and vascular peritumoral invasion are strongly prognostic in luminal breast cancer." in: Breast cancer research : BCR, Vol. 11, Issue 2, pp. R23, (2009) (PubMed).
Bretschneider, Brand, Miller, Lowery, Kerin, Gannon, Denger: "Estrogen induces repression of the breast cancer and salivary gland expression gene in an estrogen receptor alpha-dependent manner." in: Cancer research, Vol. 68, Issue 1, pp. 106-14, (2008) (PubMed).